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1. Introduction 
Diabetes mellitus is considered as a common metabolic disease diagnosed frequently in 
canine and feline pathology. On the other hand, clinical syndrome of diabetes is described 
rarely in other domestic species (cattle, small ruminants, swine and horses) [1-3]. Many 
similarities with human counterpart are clearly emphasized in the literature, considering the 
mechanism of this disease. This is the reason why the animals are frequently used in many 
research studies with respect to etiopathogenesis and treatment [4]. The most of the cases 
present as main clinical sign the failure of β-cells to produce insulin to support the metabolic 
needs of the organism. The insidious onset of diabetes may be induced by various causes: 
diminished synthesis of insulin, decreased sensitivity of target cells and organs to insulin, 
excess of other hormones and drugs or multiple combinations of these causes [1].  
Polyphagia, polyuria and polydipsia are mentioned as the most common clinical signs of 
uncomplicated diabetes mellitus (non-ketoacidotic). The animal presents persistent 
hyperglycemia generated by a low cellular uptake of glucose, increased glycogenolisis and 
gluconeogenesis from amino acid source. All these metabolic disorders are linked with a 
diminished glucose oxidation. Abnormal gluconeogenesis from amino acids will be 
clinically expressed as atrophy of the muscles and weight loss. High level of serum lipids is 
generated by increased lipolysis and decrease entry of fatty acid into adipocytes. 
Subsequently, the liver exhibits large quantities of mobilized lipids that cannot be used or 
transformed in lipoproteins. Grossly, the liver appears enlarged, even with hepatomegaly. 
Prolonged hyperglycemia will generate persistent high level of glucose in primary urine; 
these levels exceed the threshold of glucose resorption in renal tubes, thus leading to 
subsequent glucosuria, osmotic diuresis, polyuria and compensatory polydipsia. Despite of 
persistent hyperglycemia, the animal presents an increased appetite generated by the failure 
of neurons from hypothalamic satiety center to uptake the glucose [1].  
The classification of diabetes in animals is the one used for the humans, although it is not 
entirely applicable to domestic animals. 
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Type 1 (insulin dependent diabetes mellitus - IDDM) and 2 diabetes mellitus (non-insulin dependent 
diabetes mellitus - NIDDM) are generally accepted as the main form of this disease in animals. 
Specific types of diabetes (previously framed as type 3 or secondary diabetes mellitus) 
include the cases which are the consequence of insulin antagonism or other situation when 
destruction of pancreatic islets was generated by pancreatitis, pancreatic necrosis and 
tumoral processes. Gestational diabetes is a particular clinical expression of this condition, 
the occurrence being reported in dogs [5]. 
2. Diabetes mellitus in horses 
Despite all the controversies reported in the literature, it is generally accepted that horses 
develop all three forms of diabetes: insulin dependent diabetes mellitus, non-insulin 
dependent diabetes mellitus and secondary diabetes. Recent observation and studies 
recommend paying further attention and investigation to the resemblance between human 
and equine insulin resistance, which particularly develops in horses with clinical signs of 
equine metabolic syndrome (EMS). This may be expressed as obesity, associated with prior 
or concurrent rhabdomiolysis, ostechondrosis and laminitis (inflammation of the hoof wall), 
the onset of diabetes being exceptional [6-10].  
Diabetes mellitus was diagnosed in horse and pony, all cases being described in individuals 
with pancreatitis or pars intermedia pituitary tumors [11-13]. IDDM was reported mainly in 
young horses, but elderly horses are also affected (the age ranges between 5 and 18 years). 
Gender is not considered as a predisposing factor, but many of the cases were diagnosed in 
mare. Affected individuals with IDDM develop rapid weight loss despite polyphagia, as 
well as hyperglycemia, glucosuria, low insulin levels, high glycosylated hemoglobin and 
fructosamine, polydipsia and compensatory polyuria. Hepatomegaly due to hepatic 
lipidosis may occur. The pancreas exhibits segmental shrinkage, effacement of lobule 
demarcation by lymphocytic infiltrates and same inflammatory population into the 
pancreatic islets which causes severe decrease of β-cells [14]. Sometimes inflammation is not 
observed, especially in old individuals, the number of β-cells being reduced and confined to 
the periphery of the islets [15]. A case was featured by concurrent lymphocytic thyroiditis 
and adrenalitis. Thus, considering polyendocrine involvement it is postulated that 
autoimmune cause of IDDM may be suspected [14]. 
Non-insulin dependent diabetes mellitus in horse have less resemblance to human 
counterpart, comparing to cats. Particularly, insulin resistance as one of the major features of 
the type 2 diabetes in human and cats is less important for the onset of diabetes in a horse 
and more attributable to obesity, inflammation and vascular diseases. The factors which 
interfere with the effectiveness of insulin in horse are the excess of glucocorticoides, free 
fatty acids and adipokynes. Hyperinsulinemia as the result of insulin resistance may be 
maintained for years, without exhaustion of β-cell [7]. This is the reason why non-insulin 
dependent diabetes mellitus is rarely diagnosed in horses. A minimal model of analysis of 
type 2 diabetes in horse has been presented. Insulin versus glucose dynamics has been 
monitored, insulin resistance and impaired β-cell functioning being obtained [16].  
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Transient IDDM may occur in neonates. Concomitant hyperglycemia, hypoinsulinemia and 
intestinal infection with Coronavirus was reported, the foal becoming euglycemic in less 
than a year [17]. 
3. Type 1 diabetes mellitus in cattle 
Diabetes mellitus has been reported in various breeds of cattle: Holstein Fresian and 
Hereford [18, 19], Aberdeen Angus and Jersey [20], Brangus cattle [21], Charolais [22], 
Japanese brown and Japanese black [23-26]. Young individuals are constantly affected, the 
age ranging between 6 months and 5 years of age. Although there is no evidence of sex 
predilection, most of the data report cases of diabetes in females. Mild weight loss to severe 
emaciation, polyuria, polydipsia, dehydration, hyperglycemia, glucosuria and kenonuria are 
the most important clinical signs described. Previous studies mention diagnostic tests used 
in cattle: glucose tolerance test and measurements of serum fructosamine to prove that the 
most important signs of diabetes (hyperglycemia, glucosuria and kenonuria) have been 
induced by insulin deficiency. The results of these tests proved that the glucose 
disappearance rate and half time were longer than in normal control cows. Elevated values 
of serum fructosamine were also observed [22, 25].  
At necropsy, the pancreas presents normal volume or various degree of atrophy, granular 
surface due to interstitial fibrosis and yellowish-brown color of the parenchyma. The liver is 
friable and pale. The kidneys present the same discoloration, observed mainly in the cortex. 
Histologically, lymphocytic insulitis is the most important feature diagnosed. Pancreatic islets 
are reduced in size and number. The inflammatory infiltrate is represented dominantly by 
lymphocytes, few plasma cells and neutrophils being occasionally observed. The atrophied 
islets are composed by small cells, without aldehyde-fucsin and Masson-Goldner positive 
granules, proving that insulin secretion is ceased. This was supplementary proved by 
immunohistochemical investigation, almost all cells of atrophied islets being rarely reactive to 
anti-insulin antibody and poorly reactive to anti-glucagon and anti-somatostatin. Residual 
pancreatic islets present vacuolization of cytoplasm and a decreased synthesis of insulin. 
Unaffected islets may contain mitotic figures of cell nuclei. The lesions of exocrine components 
are interlobular and interacinar fibrosis, lymphocytic infiltrates around small pancreatic ducts 
and glycogen accumulation into the cytoplasm of ductal epithelial cells [23, 25].  
Several possible mechanisms of insulin-dependent diabetes mellitus onset in cattle are 
described, such as viral infection, metabolic disorders (fatty liver, fat cow syndrome), 
parturition and chronic insulitis [2].  
Considering viral infection, many studies were focused on foreign antigens exposure of 
genetically susceptible individuals. These molecules have similar biochemical structure with 
some of the components of β-cells. This way, a cell-immune mediated response is triggered 
also against islet cells. The viruses are the most suitable source of antigenic protein, bovine 
viral diarrhea virus (BVDV) and foot and mouth disease virus (FMDV) being subjected for 
extensive studies [2].  
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It is suspected that human IDDM is strongly related with viral infection as in bovine 
counterpart and include group B Coxsackie, Epstein-Bar, cytomegalovirus, herpesvirus, 
enteric rotavirus, influenza virus, rubella viruses, and mumps. This concept is highly 
supported by the results which prove epitope homology between Coxsackie B viral protein 
and glutamic acid decarboxylase – GAD (this enzyme mediates decarboxylation of 
glutamate and forms γ-aminobutiric acid - GABA). Furthermore, the cattle with IDDM do 
not express GAD in the cytoplasm of cells of atrophied islets [27-29].  
Destruction of β-cells via apoptosis seems to be controversial, generated by many pathways 
(perforin/granzyme, FasL, and other members of the necrosis factor superfamily), each of 
those mentioned being dominant or redundant in initial or late stage of cell death. Thus, 
perforin/granzyme pathway mediated by CD8+ T-lymphocytes is preferentially active 
during onset of autoimmunity. FasL is dominant in CD4+ T-cell mediated insulitis [30-32]. 
In addition, ongoing lymphocytic insulitis is preceded by releasing of many cytokines (IL-
1β, INF-γ, TNF-α) and free radicals [18, 27, 33]. Damaged proteic structures of β-cells result 
in molecules with enhanced antigenic properties, being initiated a self-perpetuating 
destruction of the cells. INF-γ and TNF-α are both responsible for increased expression of 
class I MHC molecules on β-cells [34, 35]. Combined effects of those molecules results in 
expression of class II MHC molecules on β-cells surface. Elevated expression of MHC 
molecules induces homing of lymphocytes into the islets. Activation of lymphocytes is 
initiated by INF- γ, engaging this way the responsiveness of these cells to local antigens. 
Differentiation of T-lymphocytes in IDDM shifts towards T helper lymphocytes type 1 (Th1) 
pathway. Although, Th2 pathway cytokine (IL-10) may be also involved by the effect on 
local vessels and promoting local release of other cytokines [33]. 
4. Type 1 diabetes mellitus in dog 
Spontaneous cases of insulin-dependent diabetes mellitus in dog were mentioned for the 
first time in 1861 by Leblanc and Thiernesse [36]. Later, in depth studies subjected on dog 
considered a large numbers of individuals and concluded that this condition is specific for 
older dogs and also for females [36]. Sex predilection in diabetes was further associated with 
increased incidence shortly after estrus period and in pregnant females [36-38]. A major 
breakthrough in canine diabetes mellitus was the identification of the diabetogenic effect of 
progesterone induced mammary growth hormone (GH) [39]. During the last ten years a big 
number of studies have focused on etiology of dog diabetes, especially on dog leukocyte 
antigen (DLA) and their association, candidate genes and autoantibodies [40-43]. 
Epidemiological studies on canine diabetes conducted in different part of the world 
concluded that the disease is diagnosed mainly in Samoyed, Cairn Terrier, Tibetan Terrier, 
Australian Terrier, Miniature Poodle and Schnauzer, Bichon Frise, Border Collie and some 
of the Scandinavian breeds (table 1) [37, 44, 45]. In addition, other papers complete the list 
with Labrador retriever, Yorkshire terrier, Spitz, Lhasa Apso, Beagle and Dachshund. 
Keeshonds and probably Golden retriever are potential candidate breeds due to islet 
hypoplasia, the onset of diabetes being recorded in the first months of life. Popular breeds as 
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Boxer and German shepherd seem to be resistant. Generally, canine diabetes mellitus is 
clinically diagnosed in dogs with 4-18 years of age, the median age at diagnosis being 7-9 
years [37, 44-46]. 
 
Swedish study [37] UK study [44] North America study[45] 
Australian Terrier 
Samoyed 
Swedish Lapphund 
Swedish Elkhound 
Border Collie 
Samoyed, 
Tibetan Terrier 
Cairn Terrier 
Miniature Schnauzer 
Bichon Frise 
Miniature Poodle 
Samoyed 
Cairn Terrier 
Table 1. The breeds commonly affected by diabetes mellitus 
Juvenile onset of the disease is an uncommon event and it has been recorded in dogs with 
less than 12 months of age [47-49]. Several studies concluded that females are prone to 
diabetes (more than 70% of diagnosed cases) [37]. These results are controversial with other 
studies which conclude that the number of females and male with diabetes is almost equal 
[44]. The aforementioned studies highlight that ovariohisterectomy in the first year of life 
seems to eradicate diabetes, the particular hormonal status of the dam being the cause of 
diabetes onset. These can also explain the high incidence of this condition in diestrous and 
pregnant bitches.  
The etiopathogenesis of diabetes mellitus in dog remains unclear for the majority of 
diagnosed cases. The difficulties in framing the type of diabetes come from the possible 
multifactorial etiology of the condition. Unfortunately, the human system of classification of 
diabetes is not entirely applicable to dog. The existence of NIDDM in dog is questionable, 
being known that insulin must be provided sooner or later for almost all diabetic dogs. In 
this context, it was suggested that classification of diabetes in dog would consider the 
underlying pathogenesis rather than response to insulin treatment [50]. Current diagnosis 
and therapy consider a classification system based on underlying cause of hyperglycemia: 
insulin deficiency diabetes and insulin resistance diabetes (Table 2). It is noteworthy that 
insulin resistance diabetes will be replaced progressively by insulin deficiency diabetes due 
to glucotoxicity and β-cell exhaustion [50].  
 
Insulin deficiency diabetes 
(progressive destruction of β-
cells, absolute insulin deficiency) 
β-cell hypoplasia 
Immune mediated β-cell destruction 
β-cell cell loss associated with exocrine pancreatic 
lesions (pancreatic necrosis, pancreatitis) 
Idiopathic processes 
Insulin resistance diabetes 
(relative insulin deficiency 
produced by insulin antagonists 
or concurrent disorders) 
Diestrus/gestational diabetes 
Secondary to other endocrinopathies (acromegaly, 
hyperadrenocorticism) 
Obesity 
Iatrogenic (synthetic progestagens and glucocorticoids) 
Table 2. Classification system of diabetes mellitus in dog [50] 
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Most of the diabetic dogs present unspecific destruction of Langerhans islets. Destruction of 
β-cells via autoantibodies may be considered, this being characteristic for 50% of newly 
diagnosed dogs [51]. Comparing with IDDM in human and cattle some diabetic dog express 
serological reactivity to 65kDa isoform of GAD and/or insulinoma antigen 2 (IA-2) [44, 52].  
Furthermore, there have been described some gene associations with increase susceptibility 
to diabetes in dog similar with human counterpart such as INF-γ, IL-10, IL-12β, IL-6, insulin, 
protein tyrosine phosphatase non-receptor type 22 (PTPN22), IL-4 and TNF-α, comparing 
with protective association between IL-4, PTPN22, IL-6, insulin, IGF2, TNFα [43]. Canine 
major histocompatibility complex gene known as dog leukocyte antigen (DLA) is also linked 
with the onset and progression of diabetes. Samoyed, Cairn Terrier and Tibetan Terrier 
known as prone to diabetes express DLA-DRB1*009/DQA1*001/DQB1*008 haplotype of 
MHC, comparing with resistant breeds [50].  
Inheritance of IDDM was studied and previously mentioned in Keeshonds, the genotype 
being described as autosomal recessive [41, 53]. 
Statistical analysis on a large canine population established a significant correlation between 
obesity and diabetes mellitus in Shetland Sheepdog, Dachshund, and Golden Retriever [54]. 
Hyperinsulinemia and glucose intolerance reaches the highest values in dogs with the 
highest degree of obesity [55]. The same authors concluded later that obese diabetic dogs 
can be subdivided in two groups according to the response to glucose administration: first 
group with fasting hypeinsulinemia which have a good response to glucose by increasing 
the level of insulin secretion and a second one with decompensate status featured by fasting 
hyperinsulinemia and lack of response to glucose administration. The results of the same 
study highlight that the obese dogs from this study present lower levels of insulin 
comparing with obese non-diabetic dogs [56]. It was also concluded that a high-fat diet 
generates subsequent insulin resistance which is not followed by compensatory 
hyperinsulinemia and create the premises for the onset of glucose intolerance and diabetes 
[57]. Despite to these reports, diabetes induced by insulin resistance and hyperinsulinemia 
in dog seems to be a rare condition. 
Gestational diabetes mellitus (GDM) and diestrus diabetes are rare conditions in dog, thus 
being reported only in few cases [38, 58, 59]. Pregnancy is essentially dominated be 
tremendous metabolic changes which are set for supporting fetal development. Thus, caloric 
intake, insulin secretion, peripheral insulin resistance and lipid metabolism record higher 
levels and values in pregnant dam. These metabolic changes are focused to direct glucose 
and amino acids towards fetal development, lipids being used as alternative energetic 
supply for the female. Considering this new metabolic status, β-cells from the existing 
Langerhans islets undergo hypertrophy and hyperplasia [60]. These morphological and 
functional adaptations permit high level of insulin which maintains normal glycemia. GDM 
results from the failure of this adaptive process. It is described that peripheral insulin 
resistance is upregulated by hormones such as progesterone, prolactine, cortisol and 
placental lactogens. Progesterone induced mammary growth factor hormone (GH) 
generates anti-insulin activity, being one of the most important diabetogenic hormones 
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involved in the pathogenesis of GDM [61]. Destruction of β-cells and termination of insulin 
secretion is engaged by glucotoxicity. Both pregnant and diestrous nonpregnant dams have 
higher levels of GH and lack of GAD-65 autoantibodies [38]. These findings prove that the 
onset of the diabetes is induced via ovarian hormones. Furthermore, ovariohisterectomy 
and/or termination of gestation provide a substantial improvement of the prognosis, almost 
a half of affected animals returning to normal after these surgical procedures. It is possible 
for diabetes to become a permanent status in aging animals, because of senile diminishing of 
β-cells secretion and a shortened period of tolerance to hyperglycemia [38].  
Similar pathogenic pathways to gestational diabetes mellitus are described in females with 
persistent corpora luteal and associated pseudopregnancy. Long term administration of 
synthetic progestagenes (medroxyprogesterone and megestrol acetate) initiates diabetes by 
vacuolization of β-cells [62].  
5. Type 2 diabetes mellitus in cat  
Non insulin dependent diabetes mellitus (NIDDM) is one of the most frequently 
encountered endocrinopathy in cats. Many research studies concluded that diabetic cat 
mimic some of the clinical and pathological features of human diabetes type 2: occurrence in 
obese, indoor confined, middle-aged and old individuals (highest incidence in cats with 8 
years of age), with residual and subsequent decline of insulin secretion, deposits of amyloid 
in Langerhans islets associated with loss of β-cells and onset of complications such as 
peripheral neuropathy and retinopathy. Diseases or drugs which increase the risk of insulin 
resistance such as hyperadrenocorticism, acromegaly, hyperthyroidism, renal and cardiac 
disease, administration of corticosteroids and progestagenes were also considered. Cats 
express supplementary ketoacidosis and insulin-dependence [63-67]. It is quite difficult to 
estimate the incidence of IDDM in cat: β-cell antibody did not prove any involvement in 
pathogenesis of diabetes in cat [68] and require further investigation and lymphocytic 
insulitis is rare [69]. 
The synergy between hyperinsulinemia and exaggerated response to glucose feature the 
early stages of the disease and countervail basal insulin resistance. When diabetes becomes 
overt, the compensatory insulin synthesis and secretion decline, this being usually 
accompanied by exhaustion of β-cells and amyloid deposition into the islets. Cats may 
express clinically insulin independence at the beginning of the condition, but insulin 
requirement is very probable later [67].  
The frequency of diabetes mellitus in cats records different values in a given population, 
ranging to 0.43 to 2.24%, with significant prevalence in Burmese cats. The mean age was 
significantly higher for the same breed (more than 13 years of age) comparing with short 
and longhaired domestic breeds. Males seem to be prone to diabetes, comparing with the 
incidence of the disease in females [70-72]. Juvenile diabetes is rarely described. The 
condition is clinically featured by classical symptoms, islet hypoplasia and diabetic bilateral 
cataract with both cortex and nucleus involvement [73].  
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As in humans, diabetic cats present islet amyloidosis, progressive loss of number of β and α-
cells and normal number of δ-cells. Nevertheless, these lesions are not capital for inducing 
impaired glucose tolerance in cat and also for the onset of diabetes, but it have an important 
contribution to the progression of the disease [74].  
Early stages of the disease are particularly featured by a first-phase attenuated secretion of 
insulin as response to glucose administration, followed by an exaggerated second-phase 
response. Deleterious effects as glucose toxicity, lipotoxicity and islet amyloidosis are the 
mechanism incriminated in gradual onset of diabetes.  
The onset of type 2 diabetes in cats is strongly related with glucose toxicity. Intraperitoneal 
administration of the glucose for a long time produce vacuolation of islet cells and even 
diabetes mellitus, this being one of the first experimental model in cats which prove toxic 
effect of glucose on Langerhans islets [75]. Glucotoxicity may be used as a major target of 
handling the therapy protocol of hyperglycemia, allows obtaining further preservation of β-
cells and even succeed remission of the condition. In normal individuals, glucose stimulates 
synthesis of insulin via initiating transcription of insulin gene by phosphorylation of PDX1. 
Downregulation of glucose transporters on the membrane of β-cells and decreased 
expression of insulin and PDX1 genes usually mediate hyperglycemia and subsequent 
glucose toxicity. Persistence of hyperglycemia (for at least 10 days) leads to overloading of 
β-cells with glycogen and cell death. Toxic effect of glucose is enhanced by overburden 
secretion of insulin and initiation of β-cells destruction [76, 77].  
Lipotoxicity concerns disturbances provoked by the excessive quantities of triacylglycerol 
and subsequent deposition in other non-adipose tissues (myocardium, liver, pancreas, 
skeletal muscle). Furthermore, the excess of triacylglycerol in β-cells will be expressed as 
loss of these cells and impaired synthesis of insulin; accumulation of triacylglycerol in 
muscles and liver leads to insulin resistance. The presence of triacylglycerol in the 
cytoplasm may be not sufficient to induce low levels of insulin and insulin resistance. It is 
presumed that lipolysis and synthesis of triacylglycerol are prone to produce fatty acids 
generating peroxidation compounds or other toxic lipid intermediates. Finally, these will 
initiate the expression of death receptor gene and alter insulin signaling in liver and β-cells. 
Long-chain acyl coenzyme A has been suggested as a major mediator of lipotoxicity and 
insulin resistance in non-adipose tissues [78]. The most reliable proof of this mechanism is 
offered by the skeletal muscles. High level of long-chain acyl coenzyme A into the 
sarcoplasm was correlated with decreased glucose entry. In addition, intramuscular content 
is higher in insulin-resistant animals and human [78].  
Islet amyloidosis is the dominant feature in non-insulin dependent diabetes mellitus, being 
diagnosed in more than 80% of affected domestic and wild cats [79, 80]. Amyloid deposition 
is usually detected in healthy cats, the amount increasing with the age. The prevalace of 
amyloidosis is higher in diabetic animals than in non-diabetics. The presence of amyloid is a 
hallmark for impaired β-cells function and proves previous overstimulation and exhausting 
of β-cells. The deposits are mainly extracellular, although intracellular amyloid is possible in 
non-endocrine cells of the islets, generating further disruption of the cellular membrane and 
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cell death [81]. The major component of islet amyloid is islet amyloid polypeptide or amylin 
(IAPP), based on identification of a residual fragment of this hormone [82-84]. High levels of 
IAPP are identified in obese cat and also in euglicemic cats with impaired glucose tolerance. 
Although, increased concentration of IAPP is mandatory but not exclusive in insular 
amyloid formation, other accompanying mechanisms such as defective synthesis of β-cells 
and failure of secretion, transport and degradation of IAPP are probably implicated [85]. 
There is a strong correlation between IAPP levels and pathogenesis of type 2 diabetes in 
human and cats. As a premise of the onset of diabetes in cat, increased body condition score 
in correlated with increased levels of circulating IAPP and insulin in non-diabetic cats [86]. 
Increased levels of IAPP will generate impaired glucose tolerance. Inhibitory effect of IAPP 
on glucose-stimulating insulin synthesis and increased gluconeogenesis will contribute to 
hyperglycemia. Insulin resistance of the muscle is also induced by IAPP and it results in 
inhibition of glucose uptake and further glycogenolysis. Fat tissue seems to be insensitive to 
IAPP. It is suspected that glucose resulted from muscle glicogenolysis is used in lipogenesis 
causing secondary obesity [87].  
Obesity is rightly considered as an important predisposing factor to NIDDM, being equally 
involved in the individual genetic predisposition to insulin resistance and impaired glucose 
tolerance [88]. The risk of disease results from obesity induced low sensitivity of tissues to 
insulin and compensatory hyperinsulinemia. The onset of obesity is multifactorial, with 
genetic and environmental origin. One of the cause is the presence of active “thrifty 
genotype” which allows lipogenesis when the food is plentiful and lipid mobilization when 
the food supply is diminished or absent [89]. Still, intake of large amount of highly palatable 
food with high concentration of carbohydrates, aging, neutering, and low physical exercises 
are considered important [90]. The onset of obesity is responsible of high levels of leptin and 
resistin, inflammatory cytokines such as tumor necrosis factor alpha (TNFα), interleukins 1β 
and 6, and C-reactive protein. Particularly, TNFα interfere insulin sensitivity by blocking 
activation of insulin receptors [88]. It is documented that weight gain in lean cats is followed 
by insulin sensitivity comparable with the range recorded in cats with overt diabetes. 
Furthermore, fasting-induced hyperinsulinemia in lean cats is considered to be the greatest 
risk for the onset of impaired glucose tolerance with obesity. 
Male cats have a propensity to become obese comparing female, adipose tissue mass being 
larger than obese female [70, 91]. The lack of effectiveness of insulin to reduce basal glucose 
level is proportional with mass of adipose tissue. Lean male are less insulin sensitive than 
lean female, these sensitivity recording decline when the male have weight gain. Fasting 
hyperinsulinemia is more likely to develop in obese male than obese female cats.  
Abdominal fat deposition is correlated with a more severe insulin resistance. This is also 
observed in diabetic Burmese cats which particularly have large amount of abdominal fat 
tissue and less subcutaneously [71]. 
Although obesity alone cannot induce diabetes, it is known that small increases of body 
weight and size of adipocytes result in higher risk of overt diabetes. Thus, 25% of cats which 
have weight gain have values of insulin sensitivity comparable with diabetic cats [92].  
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Insulin resistance is the expression of internalization of insulin receptors, low affinity of 
these receptors to insulin and disturbances of intracellular oxidative glucose metabolism. 
Skeletal muscle and liver present the highest expression of insulin resistance, which finally 
results into a low glycogen synthesis within the sarcoplasm and hepatocyte cytoplasm. As it 
was previously mentioned, IAPP prevents glucose uptake, inhibits glycogen synthetase and 
induce glycogenolysis followed by lactate production. The liver take lactate and initiates 
gluconeogenesis. In addition, three important insulin signaling genes are downregulated in 
liver and muscle of the moderate obese cats: insulin receptor substrate (IRS)-1, IRS-2, and 
phosphatidylinositol 3'-kinase (PI3-K) p85alpha. These data add a new resemblance between 
human and feline insulin resistance specific for NIDDM [93]. 
6. Pancreatic disease and diabetes mellitus 
The destruction of Langerhans islets via pancreatic necrosis, acute or chronic inflammation 
and tumors are presented in dogs, cats, cattle and horses.  
Particularly, canine acute pancreatitis and acute pancreatic necrosis are differentially framed 
as long as inflammation or necrosis is dominant. Thus, necrosis may be consistently 
represented comparing with inflammation and supports using the term of acute pancreatic 
necrosis (APN). This lesion is considered the common cause of diabetes mellitus in dog, 
knowing that APN is occasionally encountered in cats and sporadic in pigs and horses. 
Interestingly, the most of predisposing factors of APN are generally considered in the 
pathogenesis of diabetes mellitus. Obesity, hyperadrenocorticism, prolonged therapy with 
glucocorticoids are linked with APN and also with impaired glucose tolerance, insulin 
resistance and insulin antagonism. Most of the dogs with fatal APN express ketonuria while 
diabetic ketoacidosis can coexist with acute inflammatory lesions of the pancreas. Usually, 
all ketonuric dogs with APN or acute pancreatitis are diabetic. It is important to bear in 
mind that diabetes mellitus may create conditions for an increased risk for developing 
pancreatitis. Diabetic dogs express hypertriglyceridemia, which is a risk factor for acute 
pancreatitis [94, 95].  
Chronic pancreatitis is featured by fibrosis, atrophy of parenchyma, lymphocytic infiltrate 
and cyst of pancreatic ducts [96, 97]. The onset of chronic inflammation is a common 
consequence of the repeated mild episodes of APN or acute pancreatitis. Chronic 
pancreatitis in dogs, cats, cattle and horses is not always sufficient to induce massive 
destruction of the islets with subsequent onset of diabetes. If the magnitude of the fibrosis, 
atrophy and lymphoplasmacytic infiltrate is sufficient enough to involve large areas of the 
pancreas, than exocrine and endocrine insufficiency may develop. Nevertheless, it is 
considered that chronic pancreatitis claims an important percentage from the canine patients 
with diabetes mellitus, almost 30% of diagnosed cases were linked with histological features 
attributable to chronic inflammation of the pancreas [98]. The incidence can be higher when 
is correlated with breed predisposition [99]. 
Various morphological types of pancreatic adenocarcinoma may determine extensive 
destruction of the parenchyma and secondary diabetes in old cats and dogs [3]. The tumors 
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of islet cells are rarely described, most being diagnosed in dog. Adenomas and carcinomas 
of pancreatic islets induce hormonal hypersecretion. The dogs and also cattle, and ferrets 
can present more than one hormone in histological sections in the majority of diagnosed 
cases. Pancreatic or extrapancreatic glucagonoma is linked with diabetes mellitus and is 
featured by antagonism of glucagon with insulin. Although not pathognomonic, the 
condition is also clinically recognized by the superficial necrolytic dermatitis which affect 
muzzle, mucocutaneous junctions, ears and frictional and pressure points of the body. The 
excessive secretion of glucagon determines hyperglycemia due to the high level of hepatic 
gluconeogenesis and glycogenolysis [3, 95, 100]. 
7. Diabetogenic hormones and drugs 
Antagonists of insulin such as hormones and drugs represent an important mechanism of 
diabetes in animals. Thus, glucocorticoids, growth factor, thyroxine, glucagon, epinephrine, 
progesterone and synthetic progestagens are frequently involved. Antagonic effect is 
triggered on peripheral tissues, followed by sustained hyperglycemia and further 
exhaustion of islets. Early clinical management to monitor diabetes may be followed by 
resolution of secondary diabetes if remaining β-cells are sufficient. Finally, when 
antagonism can no longer be controlled the animals present a permanent insulin-dependent 
status.  
Hyperadrenocorticism (tumorally induced or by administration of corticosteroids as 
dexamethasone and prednisolone) [101] is one of the antagonist in dog and rarely 
encountered in cats [102-104], the new abnormal hormonal status being concurrent with 
insulin resistance. Functional adenomas or adenocarcinomas of either pituitary gland or 
adrenal cortex are responsible for hyperadrenocorticism, more than a half of affected 
animals being diabetic at the time of diagnosis. Systemic control of glycemia is poorly 
developed and expressed by classical signs. Supplementary, the animals present bad 
condition of hair coat (bilateral alopecia) and skeletal muscles, excessive fragility of the skin, 
enlarged abdomen (pot belly), bacterial infection of skin, urinary and respiratory tract [64]. 
ACTH secreting adenoma of pars intermedia associated with hyperplasia of adrenal cortex 
and reduced β-cell population was diagnosed in horse, although reference to hormonal 
antagonism is not discussed [105].  
Acromegaly as consequence of pituitary acidophil adenoma results in excessive secretion of 
growth factor (GH) and also causes associated severe insulin resistance and diabetes 
mellitus [106]. The excess of GH will generate further synthesis of insulin growth factor 1 
(IGH-1) which exerts anabolic effect and subsequent proliferation of connective tissue, 
cartilages, bones, and organs. Screening of IGH-1 provides valuable information for 
diagnosis of acromegaly in cats with overt insulin resistance, although both monitoring of 
GH and IGH-1 should be considered in addition with imaging diagnosis [107-109].  
Hyperthyroidism generates excess of thyroxine and triiodothyronine, which increase the 
bodily demands of glucose. Thus, supplementary glucose is produced in liver via 
gluconeogenesis and Cori cycle. Furthermore, fasting period allows adipose tissue lipolysis 
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which provide glycerol and fatty acids. Under these metabolic circumstances 
gluconeogenesis is initiated, glycerol resulted from lipolysis and amino acids resulted from 
proteolysis being used as basic resources. Hyperthyroid status is featured by decreased 
insulin-stimulated glycogen synthesis and increased anaerobic glycolysis. Lactate resulted 
from muscle anaerobic glycolysis and conversion to glucose into the liver maintains high 
levels of glycemia and facilitates preservation of adipose reserves [110].  
Insulin antagonism was also described as being associated with excessive secretion of 
catecholamines in animals with pheocromocytomas. Catecholamines action as inhibitors of 
insulin release and generate mild to moderate glucose intolerance [111]. Diuretics 
(hydrochlorothiazide, furosemide) induce glucose intolerance by diminishing insulin-
stimulated glucose transport into skeletal muscle and adipose tissue [112].  
8. Diabetic ketoacidosis and non-ketotic hyperosmolar diabetes 
Diabetic ketoacidosis features complicated diabetes mellitus in dog and cat, being one of the 
most severe complications. Concurrent diseases as pancreatitis, hypercorticosolism, tumoral 
diseases, infections, renal and heart failure or poor management of insulin therapy create a 
stressful status by enhancing circulating levels of insulin antagonists such as 
catecholamines, cortisol, glucagon and growth hormone. Bodily energetic demands are 
shifted to lipolysis, followed by an increase uptake of fatty acids into the liver. The absence 
of insulin and glucose into the cytoplasm will favor oxidation of fatty acids, β-hydroxibutiric 
and acetoacetic acids being released. Some of ketoacids are converted into acetone, 
volatilization through the lungs giving a specific ketone breath [113]. Clinically, the onset of 
ketoacidosis manifests as severe hyperglycemia, acidosis, ketonemia, ketonuria, 
hyperosmolarity, massive loss of magnesium, sodium, potassium, dehydration, and 
hypovolemic shock [114, 115].  
Non-ketotic hyperosmolar diabetes is characterized by hypeglicemia, hyperosmolarity, 
osmotic diuresis and subsequent dehydration. Thus, deleterious effects on central nervous 
system activity are clinically expressed as ataxia, nystagmus, seizures, hyperthermia and 
coma [116]. 
9. Lesions of diabetes mellitus in dog and cats 
Postmortem gross lesions are very little expressed in diabetic animals. Atrophy of skeletal 
muscle, dehydration and fatty liver are the principal findings. Usually, pancreas is normal, 
excepting the situation when postnecrotic scarring, chronic pancreatitis and tumors occur 
[3].  
Juvenile onset of diabetes in dog is represented by lymphocytic insulitis in almost a half of 
total number of islets. Inflammatory infiltrate is represented chiefly by T-lymphocytes, 
disposed around and inside the islets [47]. The rest of Langerhans islets presented severe 
atrophy and massive loss of β-cells. In addition to islet inflammatory lesions, other cases are 
featured by cytoplasmic vacuoles in islets cell and ductal epithelium due to massive 
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glycogen accumulation (fig.1). Lees damaged islets may present mitotic figures (fig 2). When 
insulitis do not occur, histological examination reveals only a lower number of pancreatic 
islets [49]. Amyloid deposition is characteristic for cat diabetes. The deposits are mainly 
extracellular, with particular concentration at the periphery of islets and around the 
capillaries and concurrent with depletion of islet cells (fig. 3) [79, 117].  
 
Figure 1. Cytoplasmic vacuoles in cells of Langerhans islets  in a dog with diabetes mellitus 
 
Figure 2. Mitotic figure (arrow) in a less damaged islets. 
Hepatocytes and epithelium of bile ducts express also vacuolation of the cytoplasm due to 
lipid accumulation and glycogen, respectively. Renal epithelial cells show the same 
glycogen deposits, mainly in loops of Henle and distal convoluted tubules. Renal lipidosis is 
featured by vacuoles in proximal convoluted tubes and lipidic emboli in glomerular 
capillaries [3].  
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Figure 3. Islet amyloidosis, extracellular depositions and depletion of islet cells in cat diabetes mellitus. 
(Courtesy of M. Militaru) 
The functional and structural disorders in other organs, chiefly in kidney and retina but also 
in other organs are attributable to altered vasomotor responsiveness, vasoactive mediators, 
plasma volume enhancement and tissue hypoxia, generating diabetic microangiopathy. 
Thus, increased vascular pressure and enhanced permeability in capillaries are followed by 
cell proliferation into the capillary walls and macromolecule transfer towards extravascular 
space respectively. Furthermore, these pathological effects are responsible for the thickening 
of basement membrane of the capillaries and vascular wall which induce compensatory 
dilation of less altered capillaries [118].  
Focal or diffuse diabetic glomerulosclerosis is one of the morphological expressions of 
diabetic microangiopathy. It is commonly encountered in dog and cats and indicate a long 
evolution of the disease. Basal membrane of glomerular capillaries present thickening 
caused by hyaline deposits, being followed by subsequent sclerosis of the tufts. Similar 
sclerosis occurs in mesangium and also thickening of the basement membrane of Bowman 
capsule and convoluted tubules. Dysfunctional filtration are clinically expressed in cats as 
microalbuminuria and proteinuria [119]. 
Diabetic lesions of the eye are represented by diabetic retinopathy and cataracts. As renal 
complications, retinal involvement proves a long evolution disease. Dogs and cats express 
retinopathy as microaneurysms and varicous dilations of capillaries, degenerative processes 
which result in loss of endothelial cells and pericytes and further formation of acellular non-
perfused capillaries. Neovascularization within the retina may occur [120, 121]. Cataract 
onset in dog and cats is a common event and represent the reason for which diabetes is 
suspected. The incidence is higher in dogs than cats [122], suggesting that lens capsule in 
diabetic dogs is more permeable to circulating glucose [118, 123]. 
The cats express frequently diabetic neuropathy, being clinically revealed by plantigrade 
position, hindlimb paresis and subsequent muscle atrophy [124]. The lesions are usually 
confined to pelvic sensitive and motor nerves, but thoracic limb involvement was also 
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described in juvenile onset [125]. Axonal injuries (glycogen deposition, accumulation of 
membranous deposits or neurofilaments and loss of fibers) of both myelinated and 
unmyelinated fibers, degeneration of myeline sheath featured by discontinuity (rows of 
myelin balls and ovoids), and demyelination are frequently described in feline and canine 
diabetes [126]. Microvascular changes were noticed in feline diabetic neuropathy, those 
being consistent with endoneurial dilation of capillaries and thickening of basement 
membrane [127]. Remyelination may occur if the therapy management in glucose control is 
achieved and revealed by fibers with thin myelin sheaths [128].  
Diabetic dog and cats are prone to secondary infections. Glucosuria creates good growth 
conditions for glucose and albumin fermenting bacteria (E. coli, Clostridium sp, Proteus sp, 
Staphylococcus aureus, Aerobacter aerogenes) [129] which creates gas accumulation in kidneys, 
ureters and urinary bladder. Urinary bladder wall has spongy consistency, with multiple 
cyst-like structures filled with gas, which confer floating ability when the tissue specimens 
are put into fixative solution. Hemorrhages and inflammatory cell infiltration are observed 
in lamina propria [130, 131].  
Pulmonary lesions may occur in cats with diabetes mellitus. The lesions are diverse and 
require careful clinical assessment of the individuals. Furthermore, the onset of pulmonary 
lesions are linked to vascular disturbances (congestion, edema, smooth muscle 
hypertrophy), inflammatory (pneumonia, type II pneumocytes hyperplasia, fibrosis), 
degenerative (mineralization) and neoplasia [132]. 
Impaired pigmentation (vitiligo) and canine diabetic dermathopathy are rarely seen and 
may be expressed as erythema, erosions, ulcers and crusts which feature superficial 
necrolytic dermatitis. The lesions have bilateral disposal on muzzle, lips, periocular skin, 
pinae and extremities. The onset of the lesions is attributable to decreased levels of amino 
acids which are extensively used in hepatic gluconeogenesis [3]. 
10. Diabetes mellitus in wildlife 
Spontaneous diabetes mellitus in humanoid and non-humanoid primates was described in 
captive animals and it is consistent with clinical and morphological features of type 2 
diabetes mellitus [133-139]. Thus, previous results, comparative studies and creation of 
animal models emphasized many similarities with human non-insulin dependent diabetes 
mellitus (insulin resistance, long prediabetic status and impaired β-cell function). 
Furthermore, spontaneous amyloidosis is described in various species such as rhesus 
(Macaca mulatta), squirrel monkey (Saimiri sciureus), baboons (Papio hamadryas), drills 
(Mandrillus leucophaeus, Mandrillus sphynx) , macaques (Macaca fascularis, Macaca cyclopis, 
Macaca nemestrina, Macaca nigra), Cercopithecus diana, Cercopithecus nictitans , orangutan 
(Pongo pygmaeus) and chimpanzee (Pan troglodytes). Amyloid deposits appear not only in 
pancreas, but also in spleen, liver, kidney and adrenal gland. In this context islets 
amyloidosis was immunohistochemically positive for islet amyloid polypeptide (IAPP) and 
calcitonine gene-related peptide (CGRP) [138]. Histologically, the lesions present obvious 
resemblance with those described in cat: amyloid deposition around capillaries, with little or 
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severe deleterious effect on islet cell density [134, 138, 140-142]. Complications of diabetes 
mellitus in primates are cardiomiopathy, myocardial fibrosis, nephropathy and venous 
thrombosis [143]. Secondary diabetes mellitus is described in non-humanoid monkeys with 
pituitary adenoma which creates condition for insulin antagonism [144]. 
Diabetes mellitus was described in wild captive rodents, one of the broader studies being 
conducted on golden mantled ground squirrel (Spermophilus lateralis). Grossly, the animals 
present cataract (multifocal subcapsular areas of opacity), retinal atrophy, and islet cell 
vacuolation in both α and β cells [145]. Other species of captive rodents such as tuco-tuco 
(Ctenomys talarum) [146] and plains viscachas (Lagostomus maximus) [147] may develop 
diabetes mellitus in both adults and offspring which have been diagnosed with cataract, 
hepatic lipidosis and significant high level of glucose and fructosamine. High energetic diet 
and lack of physical exercises seem to be the cause of the onset of diabetes. Wild bank vole 
(Clethrionomys glareolus) developed type 1 diabetes mellitus in adults and offspring after few 
months of captivity. The animals express typical markers for insulin dependent diabetes 
mellitus such as GAD65, IA-2 and insulin autoantibodies and vacuolation of pancreatic 
islets. A novel Picornavirus (Ljungan virus) was identified in affected islets [148, 149].  
Secondary diabetes mellitus was also described in rock hyraxes (Procavia capensis) diagnosed 
with pancreatic islet fibrosis [150] and in California sea lion due to chronic pancreatitis [151]. 
Wild carnivores develop diabetes in captive or captive-born individuals such as jaguar [152] 
and african spotted leopard [153]. Thus, secondary diabetes occurred in a female of jaguar 
(Panthera onca) with prolonged administration of megestrol acetate for preventing 
pregnancy and subsequent metastatic uterine scirrhous adenocarcinomas [152].  
A case of diabetes mellitus is described in a 50 years of age captive elephant. The bull had a 
medical history of necrotizing laminitis, poliarthritis and preputial edema treated with 
phenylbutazone, prednisolone, dexamethasone and diuretics (chlorothiazide). Pancreas 
presented atrophy and fibrosis of the islets. The authors mention that a previous infection 
with endotheliotropic elephant herpes virus should be considered as a potential cause of 
this case. Therapy protocol is also important. Although is not discussed, the usage of insulin 
antagonists in the therapy protocol may be envisaged [167]. 
Glucose metabolism in granivorous birds presents important differences comparing with 
mammals. Normal glycemia records higher values than other vertebrates with 
corresponding body weight, intracellular glycogen reserve is lower and plasma glucose 
concentration is not regulated via insulin intervention. Glucagon, insulin, somatostatin and 
avian pancreatic polypeptide are synthesized in three different types of islets [154]. The 
levels of glucagon in pancreas and plasma are higher than in mammals, this being essential 
for glucose metabolism. The absorption of glucose from gastrointestinal tract is performed 
by sodium-glucose co-transporters and glucose transport protein. These mechanisms are 
very efficient in kidneys, avian urine being glucose-free [155]. Finally, it is postulated that 
the onset of avian diabetes is probably a consequence of glucagon excess and less due to 
insulin deficiency. This has been supported by studies in ducks which have developed 
hypoglycemia after total pancreatectomy. Controversially, some experiments conducted in 
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duck and goose proved the onset of diabetes after administration of anti-insulin serum or 
subtotal pancreatectomy respectively [154]. Furthermore, some cases of avian diabetes 
mellitus have been managed successfully by insulin therapy for a long time. Carnivorous 
birds have the same insulin-coordinated glucose metabolism as described in mammals [156].  
Spontaneous diabetes mellitus in birds is rarely reported and it is consistent with type 1 
diabetes mellitus. Small parrots such as nanday conure (Nandayus nenday) [157] or in 
chestnut-fronted macaw (Ara severa) [158] present diabetes clinically expressed as polyuria, 
polydipsia, hyperglycemia, hypoinsulinemia, glucosuria and ketonuria. Pancreatic islets 
were almost totally destructed with absent immunohistochemical reaction to insulin. 
Lymphoplasmocytic pancreatitis features the lesions of exocrine pancreas in almost all cases 
described [157]. A similar situation was described in African grey parrot (Psittacus erithacus 
erithacus), in which destructions produced by pancreas inflammation were concurrent with 
compensatory proliferation and hypertrophy of the islets cells [159]. Negative results were 
obtain for identification of concurrent bacteriological and viral infection in almost all 
reviewed cases. A cockatiel (Nymphicus hollandicus) diagnosed with type 1 diabetes mellitus 
present chronic pancreatitis and associated viral inclusions in acinar and ductal epithelial 
cells due to Psittacid herpesvirus infection which indicates the diagnosis of Pacheco’s 
disease [160]. This condition is specific for Psittaciforme and it is featured by hepatic, renal 
and splenic coagulative necrosis, syncitial cells into respiratory epithelium, intestinal crypts, 
parathyroid, thymus and both intracytoplasmic and intranuclear inclusions [161, 162]. 
Although Psittacid viral infection in pancreas is rarely mentioned, the authors recommend 
differential diagnosis in avian pancreatitis with or without diabetes mellitus. It is 
noteworthy that diabetes mellitus was associated with excessive iron storage, this being a 
condition described in chestnut-fronted macaw (Ara severa), military macaw (Ara militaris) 
and also in humans [163]. This association is well documented in humans and rodent 
models of haemochromatosis, iron being preferentialy stored in β-cells and generating 
insulin deficiency [164]. Although pancreatic biopsies revealed no lesions attributable to 
iron storage in pancreatic islets, specific long term therapy succeeded to prolong survival of 
the birds more than 20 months [163]. 
Diabetes mellitus in raptors is little documented. Experimental pancreatectomy in a great 
horned owl was followed by hyperglicemia and subsequent death, proving that carnivorous 
birds develop a similar disease with humans [165]. Spontaneous diabetes mellitus was 
described in a female of red-tailed hock (Buteo jamaicensis). Kidneys, lungs and air sacs 
present different types of inflammation, as interstitial lymphocytic nephritis associated with 
cysts of proximal tubules and suppurative bronchopneumonia and aerosaculitis. Hepatic 
lipidosis was featured by isolated foci. Severe degeneration of pancreatic islets was confined 
to β-cells, characteristic glycogen granules being absent. Although bacteriological 
investigation did not identified any bacterial colonies, histological section detected cocci in 
kidneys and lungs. Postmortem examination of pituitary and adrenal glands did not 
identified tumoral lesions attributable, the etiology of the condition remaining unknown 
[166].  
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11. Conclusions 
Spontaneous diabetes mellitus in animals includes all types of diabetes described in 
humans. Although rarely diagnosed, the horses express IDDM, NIDDM and secondary 
diabetes. Cattle and dogs present IDDM, while the cat is the animal prototype of 
spontaneous NIDDM featured by islet amyloidosis. Gestational, diestrus and persistent 
corpora luteal diabetes were described in dog. The onset of diabetes in wildlife is frequently 
correlated with captivity, diet changes, low physical exercises or concurrent lesions of the 
pancreas followed by endocrine insufficiency.  
Diabetes mellitus in animals represent not only a generous field for research purpose due to 
numerous resemblances with human conditions, but also an important area in practice of 
veterinary medicine. The surveillance and treatment of diabetic animals include many issues 
to be considered, beginning with the diagnosis, continuing with causes which are 
responsible for the onset of diabetes and finishing with the setting of the most appropriate 
therapeutical protocol. Although the human diagnosis and classification of diabetes mellitus 
is not entirely applicable to animals, spontaneous onset of this disease represented the first 
steps in creating adequate animal models which became more refined to meet the various 
requirements of the research.  
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